Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
2 Preclinical modeling of human glioblastoma immunotherapy resistance using a STING pathway defective mouse model
- 12UT Health Science Center Houston, Houston, TX, USA
- 21Dana-Farber Cancer Institute, Boston, MA, USA
- 3Dana-Farber Cancer Institute, Boston, MA, USA
Related
- Single-cell RNA sequencing combined with artificial intelligence to uncover immunotherapy biomarkers and decipher drug resistance mechanisms in glioblastoma.
- Combined HDAC and ATM inhibition with radiation in preclinical glioblastoma models
- An Orthotopic Xenograft Model for Preclinical Evaluation of CAR T Cell Therapy in Glioblastoma.
- Advanced machine learning strategies for predicting therapy response in preclinical glioblastoma using longitudinal MRI
- Spatial heterogeneity in glioblastoma: linking single-cell and spatial multi-omics to vaccine immunotherapy
BibTeX
@article{chaudhri2026preclinical,
title = {{2 Preclinical modeling of human glioblastoma immunotherapy resistance using a STING pathway defective mouse model}},
author = {Apoorvi Chaudhri and Ping Hua and Gordon J Freeman and Prafulla C Gokhale and Benajmin Eschle and Maia S Lineberry and David A Reardon},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0002},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0002},
note = {CC BY},
}
RIS
TY - JOUR
TI - 2 Preclinical modeling of human glioblastoma immunotherapy resistance using a STING pathway defective mouse model
AU - Apoorvi Chaudhri
AU - Ping Hua
AU - Gordon J Freeman
AU - Prafulla C Gokhale
AU - Benajmin Eschle
AU - Maia S Lineberry
AU - David A Reardon
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0002
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0002
SN - 2051-1426
ER -